Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 257

The DOI matches its Crossref record.

Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management

BLOCK, STAN L., HARRISON, CHRISTOPHER J., HEDRICK, JAMES A., TYLER, RONALD D., SMITH, R. ALAN, KEEGAN, EILEEN, CHARTRAND, STEPHEN A.·1995·The Pediatric Infectious Disease Journal

Abstract

From January, 1992, to January, 1994, penicillin-resistant (minimal inhibition concentration (MIC) > 0.06 μg/ml) Streptococcus pneumoniae (PRSP) isolates accounted for 48 (17%) of 283 isolates from acute otitis media (AOM) or recurrent AOM in 246 ambulatory patients in rural Kentucky. By broth microdilution, relatively penicillin-resistant (MIC ≥ 0.06 to 1.0 μg/ml) and highly penicillin-resistant (MIC ≥ 2.0 μg/ml) strains were detected in 25 (16%) and 23 (15%), respectively, of 157 pneumococcal middle ear isolates. Using 1994 National Committee for Clinical Laboratory Standards breakpoints for pneumococci (unavailable for oral cephalosporins except cefuroxime), highly PRSP strains were almost uniformly susceptible to clindamycin and vancomycin. In contrast highly PRSP strains were resistant to most oral antimicrobials customarily used for AOM with one-third of strains highly resistant (MIC ≥ 2.0 μg/ml) to ceftriaxone. Serotypes 6B, 19F and 23F accounted for 95% of highly PRSP strains and serotype 9V for 48% of relatively PRSP strains. By multivariate analysis, otitis-prone condition (P = 0.0008) and number of antibiotic courses before day of culture (P < 0.0001) were independently predictive of PRSP. Highly PRSP isolates were more commonly isolated from patients recently treated within 3 days (30%) vs. those who completed therapy more than 3 days earlier (2%) (P < 0.0001). Rates of successful treatment outcome for patients with PRSP strains were: 76% (13 of 17) for amoxicillin/clavulanate, 63% (5 of 8) for amoxicillin (60 to 80 mg/kg/day) and 70% (7 of 10) for oral clindamycin for 10 to 14 days of therapy; and 78% (14 of 18) for parenteral ceftriaxone (25 or 50 mg/kg/day) once daily for 3 to 8 days. This is the first large series of prospectively identified AOM isolates in the United States to document the emergence of PRSP as a frequent pathogen of this common pediatric disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00006454-199509000-00005

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 257

Metadata

Authors
BLOCK, S. L., HARRISON, C. J., HEDRICK, J. A., TYLER, R. D., SMITH, R. A., KEEGAN, E., & CHARTRAND, S. A.
Venue
The Pediatric Infectious Disease Journal
Published
1995-09
Volume
14
Issue
9
Pages
751-759
ISSN
0891-3668 (ISSN-L)
OpenAlex
W2063959026
Cited by
257
References
0
FWCI
25.82
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. https://app.cochat.ai/papers/10.1097/00006454-199509000-00005
The paper
BLOCK, S. L., HARRISON, C. J., HEDRICK, J. A., TYLER, R. D., SMITH, R. A., KEEGAN, E., & CHARTRAND, S. A. (1995). Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. The Pediatric Infectious Disease Journal. https://doi.org/10.1097/00006454-199509000-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.